Zydus receives USFDA approval USFDA to initiate Phase II clinical trial of ZYIL1 for Parkinson's disease
Studies have demonstrated that ZYIL1 is highly potent and can suppress inflammation caused by NLRP3 inflammasome activation
Studies have demonstrated that ZYIL1 is highly potent and can suppress inflammation caused by NLRP3 inflammasome activation
Equipped with most advanced Distributed Control System (DCS) automation technology, the facility has been set up with an investment of Rs. 200 crore
Distributes Ayushman cards to several beneficiaries
Collaboration enables Brenntag to serve pharma customers in EMEA with chromatography silica gels
Evonik China and Shandong Vland Biotech agreed to build a joint venture to expand their presence in gut health solutions products for farm animals globally
Public private partnership (PPP) with integrated strategy essential to achieve ‘TB Mukt Bharat’ by 2025
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
DeltaV control system natively integrated into Sartorius Biostat STR bioreactors provide a foundation for semi-autonomous operations and up to 80% less integration time
Subscribe To Our Newsletter & Stay Updated